GFP expression by intracellular gene delivery of GFP-coding fragments using nanocrystal quantum dots
Source abstract
Abstract
Gene therapy is an attractive approach to supplement a deficient gene function. Although there has been some success with specific gene delivery using various methods including viral vectors and liposomes, most of these methods have a limited efficiency or also carry a risk for oncogenesis. We herein report that quantum dots (QDs) conjugated with nuclear localizing signal peptides (NLSP) successfully introduced gene-fragments with promoter elements, which promoted the expression of the enhanced green fluorescent protein (eGFP) gene in mammalian cells. The expression of eGFP protein was observed when the QD/gene-construct was added to the culture media. The gene-expression efficiency varied depending on multiple factors around QDs, such as (1) the reading direction of the gene-fragments, (2) the quantity of gene-fragments attached on the surface of the QD-constructs, (3) the surface electronic charges varied according to the structure of the QD/gene-constructs, and (4) the particle size of QD/gene complex varied according to the structure and amounts of gene-fragments. Using this QD/gene-construct system, eGFP protein could be detected 28 days after the gene-introduction whereas the fluorescence of QDs had disappeared. This system therefore provides another method for the intracellular delivery of gene-fragments without using either viral vectors or specific liposomes.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Virus-based gene therapy research · Quantum Dots Synthesis And Properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. 10.1089/104303404136119010.1089/1043034041361190 ↗
2. 10.1089/hum.2006.17.117710.1089/hum.2006.17.1177 ↗
3. 10.1089/10430340332212479210.1089/104303403322124792 ↗
4. 10.1089/10430340276012857710.1089/104303402760128577 ↗
5. 10.1038/7346410.1038/73464 ↗
6. 10.1182/blood-2002-10-329610.1182/blood-2002-10-3296 ↗
7. 10.1212/01.wnl.0000312381.29287.ff10.1212/01.wnl.0000312381.29287.ff ↗
8. 10.1128/JVI.79.2.955-965.200510.1128/JVI.79.2.955-965.2005 ↗
9. 10.1038/nm135810.1038/nm1358 ↗
10. 10.1128/JVI.01253-0710.1128/JVI.01253-07 ↗
11. 10.1089/hum.2008.03310.1089/hum.2008.033 ↗
12. 10.1016/j.ymthe.2005.07.35810.1016/j.ymthe.2005.07.358 ↗
13. 10.1089/hum.1995.6.7-89510.1089/hum.1995.6.7-895 ↗
14. 10.1089/hum.1995.6.12-155310.1089/hum.1995.6.12-1553 ↗
15. Schaffert D · Gene Ther. · 2008
16. 10.1038/sj.cgt.770015610.1038/sj.cgt.7700156 ↗
17. 10.1073/pnas.93.21.1142110.1073/pnas.93.21.11421 ↗
18. 10.1038/sj.gt.330271510.1038/sj.gt.3302715 ↗
19. 10.1006/mthe.2002.064710.1006/mthe.2002.0647 ↗
20. 10.1248/yakushi.127.80710.1248/yakushi.127.807 ↗
21. 10.1016/j.addr.2005.09.01710.1016/j.addr.2005.09.017 ↗
22. 10.3390/1001003410.3390/10010034 ↗
23. 10.1038/sj.mt.630021810.1038/sj.mt.6300218 ↗
24. 10.1038/sj.gt.330294510.1038/sj.gt.3302945 ↗
25. Hsieh J M · Chem. Commun. · 2006 · 61510.1039/b517368j ↗
26. 10.1038/nm109610.1038/nm1096 ↗
27. 10.1126/science.107719410.1126/science.1077194 ↗
28. 10.1007/s12282-008-0037-010.1007/s12282-008-0037-0 ↗
29. 10.1073/pnas.15246339910.1073/pnas.152463399 ↗
30. 10.1038/nbt92010.1038/nbt920 ↗
31. Hoshino A · J. Immunol. · 2007 · 178 · 529610.4049/jimmunol.178.8.5296 ↗
32. Hoshino A · Microbiol. Immunol. · 2007 · 51 · 55110.1111/j.1348-0421.2007.tb03933.x ↗
33. Ebbesen M · J. Biomed. Biotechnol. · 2006 · 2006 · 5151610.1155/JBB/2006/51516 ↗
34. 10.1016/j.ijsu.2005.10.00710.1016/j.ijsu.2005.10.007 ↗
35. 10.1016/j.copbio.2007.01.00610.1016/j.copbio.2007.01.006 ↗
36. Navalakhe R M · Indian J. Exp. Biol. · 2007 · 45 · 160
37. Arayne M S · Pak. J. Pharm. Sci. · 2006 · 19 · 258
38. Lin H · Natl Med. J. India · 2006 · 19 · 27
39. Hoshino A · J. Med. Technol. · 2006 · 50 · 1409
40. Hoshino A · Microbiol. Immunol. · 2004 · 48 · 98510.1111/j.1348-0421.2004.tb03621.x ↗
41. 10.1016/j.biomaterials.2004.06.03910.1016/j.biomaterials.2004.06.039 ↗
42. 10.1073/pnas.050492610210.1073/pnas.0504926102 ↗
43. 10.1021/nl071114c10.1021/nl071114c ↗
44. 10.1021/la701270510.1021/la7012705 ↗
45. 10.1016/j.ymthe.2006.03.01010.1016/j.ymthe.2006.03.010 ↗
46. Matsushita M · J. Neurosci. · 2001 · 21 · 600010.1523/JNEUROSCI.21-16-06000.2001 ↗
47. 10.1016/j.bbrc.2003.11.18510.1016/j.bbrc.2003.11.185 ↗
48. 10.1021/nl048715d10.1021/nl048715d ↗
49. 10.1007/s10047-007-0379-y10.1007/s10047-007-0379-y ↗
50. Fujioka K · Nanotechnology · 2008 · 19 · 41510210.1088/0957-4484/19/41/415102 ↗
51. Shiohara A · Microbiol. Immunol. · 2004 · 48 · 66910.1111/j.1348-0421.2004.tb03478.x ↗
52. 10.1117/1.276760810.1117/1.2767608 ↗
53. 10.1016/S0006-291X(03)00211-010.1016/S0006-291X(03)00211-0 ↗
54. 10.1289/ehp.828410.1289/ehp.8284 ↗